Loading
Top

The Financial Cost of Substance Abuse

According to a national survey, 22.7 million Americans struggled with substance use disorders in 2013, but only 2.5 million received treatment. The gap between those who need treatment and those who receive it occurs largely for two reasons: many addicts do not seek treatment and

Read More »

How PDMPs Protect Public Health

Prescription drug monitoring programs (or PDMPs) are state-run databases that collect patient-specific prescription information on controlled substances at the point of dispensing. Currently, 49 states, the District of Columbia and the territory of Guam have operational PDMPs. Each PDMP is overseen by a designated agency,

Read More »

The History of Heroin

The use of plant materials to relieve suffering, treat illness or in religious ceremonies has a long history. Occasionally, the Industry News section will look more closely at the history of a substance to help create context around pharmaceuticals that are a standard drug of

Read More »

Getting to the Answer: Screening vs. Confirmation Testing

Clinical toxicology testing helps clinicians and case workers help patients by providing critical information about substances in a patient’s system. There are two main testing platforms: qualitative (meaning the test is either positive or negative) and quantitative (meaning the test measures drug concentration). Screening (also

Read More »

Supporting Treatment and Recovery Through Language

Reflecting the pervasiveness of drugs in the news, the Associated Press has updated its official stylebook with new guidelines on the usage of many terms related to drugs and addiction. Updates include clarification of the distinctions between opioid and opiate, addiction and dependence, and prescribed

Read More »

Manufacturer Removes Opana ER From Market

Endo International plc, the manufacturer of an extended release formulation of oxycodone known as Opana ER, announced July 6 that it was voluntarily complying with a request from the U.S. Food and Drug Administration (FDA) to remove its product from the pharmaceutical market. The FDA

Read More »

The History of Synthetic Opioids

The use of plant materials to relieve suffering, treat illness or conduct religious ceremonies has a long history. Occasionally, the Industry News will look more closely at the history of a standard drug of interest in the toxicology industry. In the late 1920s the world

Read More »

The History of Naloxone

Widely heralded as the “antidote” to opioid overdoses, naloxone was first patented in New York in 1961 by scientists looking to treat constipation caused by chronic opioid use. Despite being related to morphine, naloxone has almost no painkilling properties, but researchers quickly recognized its ability

Read More »

Police Step Up to Fight Opioid Epidemic

Frustrated with the continually rising number of opioid overdoses, law enforcement officials across the country are taking a more active role in combating the opioid epidemic, one that does not necessarily involve making arrests. A recent New York Times article describes how public officials, police

Read More »

The Opioid Epidemic: A Plague for Modern Times

In a recent article, The New York Times estimates that more than 59,000 people died of drug overdoses in 2016, an increase of 19 percent over drug deaths in 2015. If this estimate proves to be accurate, this total would surpass deaths from car accidents

Read More »

SUBSTANCE ABUSE TREATMENT AND THE AHCA: AN OVERVIEW

Although many Democrats and Republicans agree on the need for increased access to substance abuse treatment to effectively address the opioid epidemic, treatment advocates are concerned that the House of Representatives’ newly passed American Health Care Act (AHCA) will gut funding for programs to treat

Read More »